155 related articles for article (PubMed ID: 25537728)
1. DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.
Maglic D; Stovall DB; Cline JM; Fry EA; Mallakin A; Taneja P; Caudell DL; Willingham MC; Sui G; Inoue K
J Pathol; 2015 May; 236(1):90-102. PubMed ID: 25537728
[TBL] [Abstract][Full Text] [Related]
2. Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.
Inoue K; Fry EA
Int J Cancer; 2016 Jul; 139(1):33-41. PubMed ID: 26802432
[TBL] [Abstract][Full Text] [Related]
3. Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.
Tschan MP; Federzoni EA; Haimovici A; Britschgi C; Moser BA; Jin J; Reddy VA; Sheeter DA; Fischer KM; Sun P; Torbett BE
Biochim Biophys Acta; 2015 Sep; 1849(9):1198-208. PubMed ID: 26187004
[TBL] [Abstract][Full Text] [Related]
4. Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
Taneja P; Maglic D; Kai F; Sugiyama T; Kendig RD; Frazier DP; Willingham MC; Inoue K
Cancer Res; 2010 Nov; 70(22):9084-94. PubMed ID: 21062982
[TBL] [Abstract][Full Text] [Related]
5. Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.
Fry EA; Taneja P; Maglic D; Zhu S; Sui G; Inoue K
PLoS One; 2013; 8(10):e77870. PubMed ID: 24205004
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.
Zhu S; Mott RT; Fry EA; Taneja P; Kulik G; Sui G; Inoue K
Am J Pathol; 2013 Oct; 183(4):1339-1350. PubMed ID: 23938323
[TBL] [Abstract][Full Text] [Related]
7. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.
Sum EY; Segara D; Duscio B; Bath ML; Field AS; Sutherland RL; Lindeman GJ; Visvader JE
Proc Natl Acad Sci U S A; 2005 May; 102(21):7659-64. PubMed ID: 15897450
[TBL] [Abstract][Full Text] [Related]
9. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
Pan Y; Wang L; Dai JL
Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin sensitivity in breast cancer cells is associated with particular DMTF1 splice variant expression.
Niklaus NJ; Humbert M; Tschan MP
Biochem Biophys Res Commun; 2018 Sep; 503(4):2800-2806. PubMed ID: 30100063
[TBL] [Abstract][Full Text] [Related]
11. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
[TBL] [Abstract][Full Text] [Related]
13. Dmp1 and tumor suppression.
Inoue K; Mallakin A; Frazier DP
Oncogene; 2007 Jun; 26(30):4329-35. PubMed ID: 17237816
[TBL] [Abstract][Full Text] [Related]
14. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
15. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
16. Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma.
Tanaka N; Yoshida H; Suzuki Y; Harigaya K
Int J Oncol; 2014 Nov; 45(5):1921-8. PubMed ID: 25109497
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction involving the dmp1 transcription factor and its alteration in human cancer.
Sugiyama T; Frazier DP; Taneja P; Kendig RD; Morgan RL; Matise LA; Lagedrost SJ; Inoue K
Clin Med Oncol; 2008; 2():209-19. PubMed ID: 21892281
[TBL] [Abstract][Full Text] [Related]
19. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]